Abstract
The objectification of pain presents a significant clinical challenge, particularly in children, elderly individuals, patients with disabilities and unconscious patients. It is critically important to accurately assess pain in these populations due to the heightened risk of undertreatment. Using the cold pressor test (CPT) as a pain induction model, we combined real-time breath metabolomics with pathway analysis to uncover metabolic shifts. Exhaled breath was analyzed in a discovery cohort (n=19) and validated in an independent cohort (n=21) using secondary electrospray ionization-high-resolution mass spectrometry (SESI-HRMS). Within 15 minutes of CPT, over 400 conserved mass spectral features were significantly altered across both cohorts. Pathway analysis highlighted shifts in aminoacyl-tRNA biosynthesis, cysteine/methionine metabolism, butanoate metabolism, and arginine/proline metabolism. Arginine and glutamate, key contributors to nitric oxide production and nociceptive signaling, exhibited consistent upregulation. Neural network classifiers achieved robust differentiation between pre- and post-CPT profiles (AUC=0.856), showcasing breath metabolomics as a promising observer independent, and objective tool for real-time pain assessment. To validate universal mechanistic relevance of the findings, we compared them to findings of chronic pain studies revealing consistencies in amino acid and neurotransmitter-related pathways. This study provides novel insights into the metabolic basis of acute pain and positions breath metabolomics as a viable approach for dynamic, observer independent monitoring pain in vulnerable patient groups. Future research must determine if these new insights into mechanistic pathways can inform patient- and disease-specific pain management strategies.
Introduction
Pain assessment is inherently subjective, typically relying on self-reporting or behavioral observations. This creates a significant "objectification gap" for vulnerable populations—such as infants, patients with dementia, or those in intensive care—who cannot communicate their distress. While physiological markers like heart rate or skin conductance are sometimes used, they often lack the specificity or speed required for real-time monitoring. This study investigates whether "exhalomics"—the real-time analysis of metabolites in exhaled breath—can provide a rapid, objective, and observer-independent metric for acute pain.
Experimental Design and Workflow
To induce a controlled pain response, researchers utilized the Cold Pressor Test (CPT), where participants submerged a hand in 2°C water until the pain became intolerable. The metabolic response was captured using Secondary Electrospray Ionization-High-Resolution Mass Spectrometry (SESI-HRMS), a technology that allows for the instantaneous ionization and analysis of molecules as a subject breathes into the machine.
The study employed a rigorous discovery-and-validation structure across two international cohorts: a discovery cohort in Switzerland (n=19) and a validation cohort in China (n=21). This cross-continental approach was designed to ensure that any identified metabolic signature represented a fundamental biological response to pain rather than a demographic or environmental artifact.
Key Insights and Results
Rapid Metabolic Shifts
The study revealed that the breath metabolome is highly dynamic, with significant changes detectable within just 15 minutes of the pain stimulus. Over 400 mass spectral features were consistently altered across both the Swiss and Chinese cohorts, suggesting a conserved "breathprint" for acute pain.
The Arginine-Glutamate Axis
Pathway analysis identified several key biological processes involved in the pain response, most notably the upregulation of arginine and glutamate. Arginine serves as a precursor to nitric oxide, which regulates vascular tone during stress, while glutamate is the primary excitatory neurotransmitter involved in nociception (pain signaling). The consistent elevation of these markers suggests that the body rapidly reconfigures its chemistry to mobilize energy and manage the physiological stress of pain.
Machine Learning Classification
A Multi-Layer Perceptron (neural network) was trained to classify breath samples as "pre-pain" or "post-pain." The model achieved an Area Under the Curve (AUC) of 0.856 and an overall accuracy of 78%. Notably, the model was most accurate (92.5%) at identifying the initial baseline measurements, though performance slightly decreased during intermediate phases where anticipatory anxiety might have influenced the metabolic profile.
Discussion and Clinical Implications
The findings suggest a universal metabolic basis for pain, as the shifts observed in this acute model mirrored metabolic patterns previously identified in chronic pain literature. By bridging the gap between subjective experience and objective measurement, breath metabolomics offers a promising tool for clinical settings where patient communication is impossible.
However, limitations remain. Future work must determine if this metabolic signature is unique to pain or a more general response to cold and sympathetic nervous system activation. Additionally, while database matching provided high-probability identifications for metabolites, further tandem mass spectrometry (MS/MS) is needed for definitive confirmation. Expanding these studies to real-world clinical environments, such as pediatric wards and ICUs, will be the next critical step in validating this "breathprint" for routine medical use.
Summary updated